{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:09:18Z","timestamp":1793729358905,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"\u201cQimingxing\u201d Research Fund for Young Talents of West China Hospital","award":["No.HXQMX0105"],"award-info":[{"award-number":["No.HXQMX0105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04413-6","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:23:04Z","timestamp":1757013784000},"page":"1149-1167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relationship between affected family members and clinical aggressiveness in Familial non-medullary thyroid carcinoma: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"90","author":[{"given":"Guang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-9129","authenticated-orcid":false,"given":"Tao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"5","key":"4413_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"L. Boucai, M. Zafereo, M.E. Cabanillas, Thyroid cancer: A review. JAMA 331(5), 425\u2013435 (2024). https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"JAMA"},{"key":"4413_CR2","unstructured":"N. Howlader, A.M. Noone, M. Krapcho et al., (2017) SEER Cancer Statistics Review, 1975\u20132014. National Cancer Institute, Bethesda, MD. https:\/\/seer.cancer.gov\/csr\/1975_2014"},{"issue":"2","key":"4413_CR3","doi-asserted-by":"publisher","first-page":"e855","DOI":"10.1210\/clinem\/dgaa798","volume":"106","author":"M Capezzone","year":"2021","unstructured":"M. Capezzone, A. Sagnella, T. Pilli, F. Maino, R. Forleo, S. Cantara, A. Cartocci, M.G. Castagna, Role of age at diagnosis in defining potential Familial nonmedullary thyroid cancer in kindreds with two affected members. J. Clin. Endocrinol. Metab. 106(2), e855\u2013e865 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgaa798","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4413_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.23736\/S2724-6507.20.03338-6","volume":"46","author":"V Cirello","year":"2021","unstructured":"V. Cirello, Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors. Minerva Endocrinol. 46(1), 5\u201320 (2021). https:\/\/doi.org\/10.23736\/S2724-6507.20.03338-6","journal-title":"Minerva Endocrinol."},{"issue":"2","key":"4413_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/thy.2006.16.181","volume":"16","author":"ND Charkes","year":"2006","unstructured":"N.D. Charkes, On the prevalence of Familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid: Official J. Am. Thyroid Association. 16(2), 181\u2013186 (2006). https:\/\/doi.org\/10.1089\/thy.2006.16.181","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"3","key":"4413_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12020-020-02250-3","volume":"68","author":"SA Ammar","year":"2020","unstructured":"S.A. Ammar, W.M. Alobuia, E. Kebebew, An update on Familial nonmedullary thyroid cancer. Endocrine. 68(3), 502\u2013507 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02250-3","journal-title":"Endocrine"},{"issue":"10","key":"4413_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ejso.2016.08.006","volume":"42","author":"IJ Nixon","year":"2016","unstructured":"I.J. Nixon, C. Su\u00e1rez, R. Simo, A. Sanabria, P. Angelos, A. Rinaldo, J.P. Rodrigo, L.P. Kowalski, D.M. Hartl, M.L. Hinni, J.P. Shah, A. Ferlito, The impact of family history on non-medullary thyroid cancer. Eur. J. Surg. Oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol. 42(10), 1455\u20131463 (2016). https:\/\/doi.org\/10.1016\/j.ejso.2016.08.006","journal-title":"Eur. J. Surg. Oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol."},{"issue":"8","key":"4413_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00268-002-6615-y","volume":"26","author":"S Uchino","year":"2002","unstructured":"S. Uchino, S. Noguchi, H. Kawamoto, H. Yamashita, S. Watanabe, H. Yamashita, S. Shuto, Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J. Surg. 26(8), 897\u2013902 (2002). https:\/\/doi.org\/10.1007\/s00268-002-6615-y","journal-title":"World J. Surg."},{"key":"4413_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12957-015-0519-4","volume":"13","author":"S Lei","year":"2015","unstructured":"S. Lei, D. Wang, J. Ge, H. Liu, D. Zhao, G. Li, Z. Ding, Single-center study of Familial papillary thyroid cancer in china: surgical considerations. World J. Surg. Oncol. 13, 115 (2015). https:\/\/doi.org\/10.1186\/s12957-015-0519-4","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"4413_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/thy.2011.0192","volume":"22","author":"H Mazeh","year":"2012","unstructured":"H. Mazeh, J. Benavidez, J.L. Poehls, L. Youngwirth, H. Chen, R.S. Sippel, In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid: Official J. Am. Thyroid Association. 22(1), 3\u20138 (2012). https:\/\/doi.org\/10.1089\/thy.2011.0192","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"4413_CR11","unstructured":"L. Jiwang, L. Zhendong, L. Shuchun, H. Bo, L. Yanguo, (2015). Clinicopathologic characteristics of Familial versus sporadic papillary thyroid carcinoma. Acta otorhinolaryngologica italica: organo ufficiale Della societa Italiana Di otorinolaringologia e chirurgia cervico-facciale, 35(4), 234\u2013242"},{"issue":"2","key":"4413_CR12","doi-asserted-by":"publisher","first-page":"E677","DOI":"10.1002\/lary.28989","volume":"131","author":"L Muallem Kalmovich","year":"2021","unstructured":"L. Muallem Kalmovich, B. Jabarin, S. Koren, K. Or, E. Marcus, I. Tkacheva, C. Benbassat, M. Steinschneider, Is Familial nonmedullary thyroid cancer A more aggressive type of thyroid cancer? Laryngoscope. 131(2), E677\u2013E681 (2021). https:\/\/doi.org\/10.1002\/lary.28989","journal-title":"Laryngoscope"},{"issue":"1","key":"4413_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/thy.2009.0406","volume":"21","author":"E Robenshtok","year":"2011","unstructured":"E. Robenshtok, G. Tzvetov, S. Grozinsky-Glasberg, I. Shraga-Slutzky, R. Weinstein, L. Lazar, S. Serov, J. Singer, D. Hirsch, I. Shimon, C. Benbassat, Clinical characteristics and outcome of Familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid: Official J. Am. Thyroid Association. 21(1), 43\u201348 (2011). https:\/\/doi.org\/10.1089\/thy.2009.0406","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"4","key":"4413_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/thy.2010.0256","volume":"21","author":"W Moses","year":"2011","unstructured":"W. Moses, J. Weng, E. Kebebew, Prevalence, clinicopathologic features, and somatic genetic mutation profile in Familial versus sporadic nonmedullary thyroid cancer. Thyroid: Official J. Am. Thyroid Association. 21(4), 367\u2013371 (2011). https:\/\/doi.org\/10.1089\/thy.2010.0256","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"2","key":"4413_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1530\/EJE-13-0865","volume":"170","author":"AE Pinto","year":"2013","unstructured":"A.E. Pinto, G.L. Silva, R. Henrique, F.D. Menezes, M.R. Teixeira, V. Leite, B.M. Cavaco, Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical\/prognostic behaviour. Eur. J. Endocrinol. 170(2), 321\u2013327 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0865","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4413_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.surg.2018.05.075","volume":"165","author":"M El Lakis","year":"2019","unstructured":"El M. Lakis, A. Giannakou, P.J. Nockel, D. Wiseman, S.K. Gara, D. Patel, Z.A. Sater, Y.Y. Kushchayeva, J. Klubo-Gwiezdzinska, N. Nilubol, M.J. Merino, E. Kebebew, Do patients with Familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment. Surgery. 165(1), 50\u201357 (2019). https:\/\/doi.org\/10.1016\/j.surg.2018.05.075","journal-title":"Surgery"},{"issue":"4","key":"4413_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4103\/0366-6999.225054","volume":"131","author":"YB Zhang","year":"2018","unstructured":"Y.B. Zhang, X.X. Wang, X.W. Zhang, Z.J. Li, J. Liu, Z.G. Xu, P.Z. Tang, Familial nonmedullary thyroid carcinoma: A retrospective analysis of 117 families. Chin. Med. J. 131(4), 395\u2013401 (2018). https:\/\/doi.org\/10.4103\/0366-6999.225054","journal-title":"Chin. Med. J."},{"issue":"5","key":"4413_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00268-005-0398-x","volume":"30","author":"F Triponez","year":"2006","unstructured":"F. Triponez, M. Wong, C. Sturgeon, N. Caron, D.G. Ginzinger, M.R. Segal, E. Kebebew, Q.Y. Duh, O.H. Clark, Does Familial non-medullary thyroid cancer adversely affect survival? World J. Surg. 30(5), 787\u2013793 (2006). https:\/\/doi.org\/10.1007\/s00268-005-0398-x","journal-title":"World J. Surg."},{"key":"4413_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, R. Chou, J. Glanville, J.M. Grimshaw, A. Hr\u00f3bjartsson, M.M. Lalu, T. Li, E.W. Loder, E. Mayo-Wilson, S. McDonald, L.A. McGuinness, D. Moher, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J. Clin. Epidemiol. 134, 178\u2013189 (2021). https:\/\/doi.org\/10.1016\/j.jclinepi.2021.03.001","journal-title":"J. Clin. Epidemiol."},{"key":"4413_CR20","unstructured":"G.A. Wells, B. Shea, D. O\u2019Connell et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"4413_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"J.F. Tierney, L.A. Stewart, D. Ghersi, S. Burdett, M.R. Sydes, Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 8, 16 (2007). https:\/\/doi.org\/10.1186\/1745-6215-8-16","journal-title":"Trials"},{"issue":"4","key":"4413_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"C.B. Begg, M. Mazumdar, Operating characteristics of a rank correlation test for publication bias. Biometrics. 50(4), 1088\u20131101 (1994)","journal-title":"Biometrics"},{"issue":"7109","key":"4413_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"M. Egger, G. Davey Smith, M. Schneider, C. Minder, Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Res. ed.). 315(7109), 629\u2013634 (1997). https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ (Clinical Res. ed.)"},{"issue":"3","key":"4413_CR24","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3892\/ol.2015.3386","volume":"10","author":"M Landriscina","year":"2015","unstructured":"M. Landriscina, M.I. Natalicchio, O. Lamacchia, A. Conserva, A. Piscazzi, A. Ciampolillo, M. Zingrillo, A. Pennella, P. Bufo, G. Vita, R. Antonetti, E. Maiorano, F. Giorgino, M. Cignarelli, RAS\/BRAF mutational status in Familial non-medullary thyroid carcinomas: A retrospective study. Oncol. Lett. 10(3), 1875\u20131881 (2015). https:\/\/doi.org\/10.3892\/ol.2015.3386","journal-title":"Oncol. Lett."},{"issue":"8","key":"4413_CR25","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1007\/s00268-015-3064-y","volume":"39","author":"TY Sung","year":"2015","unstructured":"T.Y. Sung, Y.M. Lee, J.H. Yoon, K.W. Chung, S.J. Hong, Surgical management of Familial papillary thyroid microcarcinoma: A single institution study of 94 cases. World J. Surg. 39(8), 1930\u20131935 (2015). https:\/\/doi.org\/10.1007\/s00268-015-3064-y","journal-title":"World J. Surg."},{"issue":"4","key":"4413_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000506955","volume":"9","author":"M Capezzone","year":"2020","unstructured":"M. Capezzone, N. Fralassi, C. Secchi, S. Cantara, L. Brilli, T. Pilli, F. Maino, R. Forleo, F. Pacini, G. Cevenini, A. Cartocci, M.G. Castagna, Long-Term clinical outcome in Familial and sporadic papillary thyroid carcinoma. Eur. Thyroid J. 9(4), 213\u2013220 (2020). https:\/\/doi.org\/10.1159\/000506955","journal-title":"Eur. Thyroid J."},{"key":"4413_CR27","doi-asserted-by":"publisher","unstructured":"T.J. McDonald, A.A. Driedger, B.M. Garcia, Van S.H. Uum, I. Rachinsky, V. Chevendra, D. Breadner, R. Feinn, S.J. Walsh, C.D. Malchoff, (2011). Familial papillary thyroid carcinoma: a retrospective analysis. Journal of oncology, 2011, 948786. https:\/\/doi.org\/10.1155\/2011\/948786","DOI":"10.1155\/2011\/948786"},{"key":"4413_CR28","doi-asserted-by":"publisher","unstructured":"A. Hillenbrand, J.E. Varhaug, M. Brauckhoff, R. Pandev, S. Haufe, C. Dotzenrath, R. K\u00f6berle, R. Hoffmann, G. Klein, M. Kadmon, T. Negele, T. Hagieva, D. Henne-Bruns, M. Luster, T. Weber, (2010). Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation. Langenbeck\u2019s archives of surgery, 395(7), 851\u2013858. https:\/\/doi.org\/10.1007\/s00423-010-0696-0","DOI":"10.1007\/s00423-010-0696-0"},{"issue":"2","key":"4413_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jso.23447","volume":"109","author":"YM Lee","year":"2014","unstructured":"Y.M. Lee, J.H. Yoon, O. Yi, T.Y. Sung, K.W. Chung, W.B. Kim, S.J. Hong, Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. J. Surg. Oncol. 109(2), 168\u2013173 (2014). https:\/\/doi.org\/10.1002\/jso.23447","journal-title":"J. Surg. Oncol."},{"issue":"8","key":"4413_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4103\/0366-6999.155075","volume":"128","author":"YF Fan","year":"2015","unstructured":"Y.F. Fan, B. Zhang, X. Yang, Z.H. Shang, H.F. Liu, Y. Xie, Y.W. Liu, W.S. Gao, Q. Wu, X.Y. Li, Clinicopathologic features of Familial nonmedullary thyroid carcinoma. Chin. Med. J. 128(8), 1037\u20131041 (2015). https:\/\/doi.org\/10.4103\/0366-6999.155075","journal-title":"Chin. Med. J."},{"key":"4413_CR31","doi-asserted-by":"publisher","first-page":"616974","DOI":"10.3389\/fonc.2021.616974","volume":"11","author":"T Yang","year":"2021","unstructured":"T. Yang, L. Huang, C. Chen, H. Luo, Y. Jiang, Comparison between clinicopathological characteristics, BRAF V600E and TERT promoter mutation of Familial Non-Medullary thyroid carcinomas, and sporadic case. Front. Oncol. 11, 616974 (2021). https:\/\/doi.org\/10.3389\/fonc.2021.616974","journal-title":"Front. Oncol."},{"issue":"4","key":"4413_CR32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/cen.12859","volume":"84","author":"J Cao","year":"2016","unstructured":"J. Cao, C. Chen, C. Chen, Q.L. Wang, M.H. Ge, Clinicopathological features and prognosis of Familial papillary thyroid carcinoma\u2013a large-scale, matched, case-control study. Clin. Endocrinol. 84(4), 598\u2013606 (2016). https:\/\/doi.org\/10.1111\/cen.12859","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"4413_CR33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3906\/sag-1907-94","volume":"50","author":"H Sezer","year":"2020","unstructured":"H. Sezer, M.O. Demirkol, D. Yazici, Y. Kapran, M.F. Alag\u00f6l, The clinicopathologic characteristics of Familial and sporadic papillary thyroid carcinoma in Turkish patients. Turk. J. Med. Sci. 50(2), 360\u2013368 (2020). https:\/\/doi.org\/10.3906\/sag-1907-94","journal-title":"Turk. J. Med. Sci."},{"key":"4413_CR34","doi-asserted-by":"publisher","first-page":"1200855","DOI":"10.3389\/fendo.2023.1200855","volume":"14","author":"Z Li","year":"2023","unstructured":"Z. Li, H. Zhang, Y. Yan, X. Li, M. Jia, H. Zhou, X. Lu, Clinical relevance and outcome of Familial papillary thyroid cancer: a single institution study of 626 Familial cases. Front. Endocrinol. 14, 1200855 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1200855","journal-title":"Front. Endocrinol."},{"issue":"4","key":"4413_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.endien.2022.03.003","volume":"69","author":"J de Carlos Artajo","year":"2022","unstructured":"de J. Carlos Artajo, A. Irigaray Echarri, J. Garc\u00eda Torres, J.J. Pineda Arribas, A. Ernaga Lorea, N. Egu\u00edlaz Esparza, J.M. Zubir\u00eda Gort\u00e1zar, E. Anda Api\u00f1\u00e1niz, Clinical characteristics and prognosis of Familial nonmedullary thyroid carcinoma. Endocrinologia Diabetes Y Nutricion. 69(4), 262\u2013270 (2022). https:\/\/doi.org\/10.1016\/j.endien.2022.03.003","journal-title":"Endocrinologia Diabetes Y Nutricion"},{"issue":"3","key":"4413_CR36","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1245\/s10434-020-09025-0","volume":"28","author":"YM Lee","year":"2021","unstructured":"Y.M. Lee, M.J. Jeon, W.W. Kim, K.W. Chung, J.H. Baek, Y.K. Shong, T.Y. Sung, S.J. Hong, Comparison between Familial and sporadic Non-medullary thyroid carcinoma: A retrospective individual risk Factor-Matched cohort study. Ann. Surg. Oncol. 28(3), 1722\u20131730 (2021). https:\/\/doi.org\/10.1245\/s10434-020-09025-0","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"4413_CR37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1067\/msy.2000.110848","volume":"128","author":"O Alsanea","year":"2000","unstructured":"O. Alsanea, N. Wada, K. Ain, M. Wong, K. Taylor, P.H. Ituarte, P.A. Treseler, H.U. Weier, N. Freimer, A.E. Siperstein, Q.Y. Duh, H. Takami, O.H. Clark, Is Familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery. 128(6), 1043\u20131051 (2000). https:\/\/doi.org\/10.1067\/msy.2000.110848","journal-title":"Surgery"},{"issue":"6","key":"4413_CR38","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/EJE-14-0960","volume":"172","author":"X Wang","year":"2015","unstructured":"X. Wang, W. Cheng, J. Li, A. Su, T. Wei, F. Liu, J. Zhu, Endocrine tumours: Familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis. Eur. J. Endocrinol. 172(6), R253\u2013R262 (2015). https:\/\/doi.org\/10.1530\/EJE-14-0960","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"4413_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2009.1607","volume":"19","author":"MR Vriens","year":"2009","unstructured":"M.R. Vriens, I. Suh, W. Moses, E. Kebebew, Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid: Official J. Am. Thyroid Association. 19(12), 1343\u20131349 (2009). https:\/\/doi.org\/10.1089\/thy.2009.1607","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"5","key":"4413_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1530\/EJE-14-0225","volume":"171","author":"H Choi","year":"2014","unstructured":"H. Choi, J.A. Lim, H.Y. Ahn, S.W. Cho, K.E. Lee, K.W. Kim, K.H. Yi, M.W. Sung, Y.K. Youn, J.K. Chung, Y.J. Park, D.J. Park, B.Y. Cho, Secular trends in the prognostic factors for papillary thyroid cancer. Eur. J. Endocrinol. 171(5), 667\u2013675 (2014). https:\/\/doi.org\/10.1530\/EJE-14-0225","journal-title":"Eur. J. Endocrinol."},{"key":"4413_CR41","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.12659\/msm.895564","volume":"22","author":"W Zhang","year":"2016","unstructured":"W. Zhang, D. Jiao, B. Liu, S. Sun, Analysis of risk factors contributing to recurrence of papillary thyroid carcinoma in Chinese patients who underwent total thyroidectomy. Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res. 22, 1274\u20131279 (2016). https:\/\/doi.org\/10.12659\/msm.895564","journal-title":"Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res."},{"issue":"6","key":"4413_CR42","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.surg.2013.06.019","volume":"154","author":"SM Sadowski","year":"2013","unstructured":"S.M. Sadowski, M. He, K. Gesuwan, N. Gulati, F. Celi, M.J. Merino, N. Nilubol, E. Kebebew, Prospective screening in Familial nonmedullary thyroid cancer. Surgery. 154(6), 1194\u20131198 (2013). https:\/\/doi.org\/10.1016\/j.surg.2013.06.019","journal-title":"Surgery"},{"issue":"8","key":"4413_CR43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1089\/thy.2016.0668","volume":"27","author":"J Klubo-Gwiezdzinska","year":"2017","unstructured":"J. Klubo-Gwiezdzinska, L. Yang, R. Merkel, D. Patel, N. Nilubol, M.J. Merino, M. Skarulis, S.M. Sadowski, E. Kebebew, Results of screening in Familial Non-Medullary thyroid cancer. Thyroid: Official J. Am. Thyroid Association. 27(8), 1017\u20131024 (2017). https:\/\/doi.org\/10.1089\/thy.2016.0668","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"6","key":"4413_CR44","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1210\/jc.2017-02599","volume":"103","author":"CM Kitahara","year":"2018","unstructured":"C.M. Kitahara, K. Rmendin\u00e9 Farkas, D. J\u00f8rgensen, J.O.L. Cronin-Fenton, D., H.T. S\u00f8rensen, Benign thyroid diseases and risk of thyroid cancer: A nationwide cohort study. J. Clin. Endocrinol. Metab. 103(6), 2216\u20132224 (2018). https:\/\/doi.org\/10.1210\/jc.2017-02599","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4413_CR45","doi-asserted-by":"publisher","unstructured":"V. Nos\u00e9, (2011). Familial thyroid cancer: a review. Modern pathology: an official journal of the united States and Canadian academy of pathology, inc, 24 Suppl 2, S19\u2013S33. https:\/\/doi.org\/10.1038\/modpathol.2010.147","DOI":"10.1038\/modpathol.2010.147"},{"key":"4413_CR46","doi-asserted-by":"publisher","first-page":"801925","DOI":"10.3389\/fendo.2022.801925","volume":"13","author":"J Xu","year":"2022","unstructured":"J. Xu, K. Ding, L. Mu, J. Huang, F. Ye, Y. Peng, C. Guo, C. Ren, Hashimoto\u2019s thyroiditis: A Double-Edged sword in thyroid carcinoma. Front. Endocrinol. 13, 801925 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.801925","journal-title":"Front. Endocrinol."},{"key":"4413_CR47","doi-asserted-by":"publisher","unstructured":"F.M. Hanege, O. Tuysuz, S. Celik, O. Sakall\u0131oglu, A. Solmaz, O. (2021). Hashimoto\u2019s thyroiditis in papillary thyroid carcinoma: a 22-year study. Acta otorhinolaryngologica Italica: organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 41(2), 142\u2013145. https:\/\/doi.org\/10.14639\/0392-100X-N1081","DOI":"10.14639\/0392-100X-N1081"},{"key":"4413_CR48","doi-asserted-by":"publisher","first-page":"1512417","DOI":"10.3389\/fendo.2025.1512417","volume":"16","author":"S Yao","year":"2025","unstructured":"S. Yao, H. Zhang, Papillary thyroid carcinoma with hashimoto\u2019s thyroiditis: impact and correlation. Front. Endocrinol. 16, 1512417 (2025). https:\/\/doi.org\/10.3389\/fendo.2025.1512417","journal-title":"Front. Endocrinol."},{"issue":"1","key":"4413_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jss.2007.09.020","volume":"150","author":"D Repplinger","year":"2008","unstructured":"D. Repplinger, A. Bargren, Y.W. Zhang, J.T. Adler, M. Haymart, H. Chen, Is hashimoto\u2019s thyroiditis a risk factor for papillary thyroid cancer? J. Surg. Res. 150(1), 49\u201352 (2008). https:\/\/doi.org\/10.1016\/j.jss.2007.09.020","journal-title":"J. Surg. Res."},{"key":"4413_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-025-02029-4","author":"J Cao","year":"2025","unstructured":"J. Cao, X. Li, H. Liang, Y. Li, F. Zhao, A. Dong, The efficacy analysis of radioactive iodine therapy for Familial non-medullary thyroid cancer in the era of personalized medicine: a cohort study and a meta-analysis. Ann. Nucl. Med. (2025). https:\/\/doi.org\/10.1007\/s12149-025-02029-4. Advance online publication","journal-title":"Ann. Nucl. Med."},{"issue":"9","key":"4413_CR51","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s00268-020-05473-7","volume":"44","author":"YS Kim","year":"2020","unstructured":"Y.S. Kim, M. Seo, S.H. Park, S.Y. Ju, E.S. Kim, Should total thyroidectomy be recommended for patients with Familial Non-medullary thyroid cancer?? World J. Surg. 44(9), 3022\u20133027 (2020). https:\/\/doi.org\/10.1007\/s00268-020-05473-7","journal-title":"World J. Surg."},{"issue":"4","key":"4413_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/thy.2011.0163","volume":"22","author":"YJ Park","year":"2012","unstructured":"Y.J. Park, H.Y. Ahn, H.S. Choi, K.W. Kim, D.J. Park, B.Y. Cho, The long-term outcomes of the second generation of Familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid: Official J. Am. Thyroid Association. 22(4), 356\u2013362 (2012). https:\/\/doi.org\/10.1089\/thy.2011.0163","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"12","key":"4413_CR53","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.ejso.2017.09.005","volume":"43","author":"YM Zhou","year":"2017","unstructured":"Y.M. Zhou, H. Luo, J.X. Gou, W.J. Zhao, W.Y. Dai, J. Zhu, Z.H. Li, Second generation of Familial nonmedullary thyroid carcinoma: A meta-analysis on the clinicopathologic features and prognosis. Eur. J. Surg. Oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol. 43(12), 2248\u20132256 (2017). https:\/\/doi.org\/10.1016\/j.ejso.2017.09.005","journal-title":"Eur. J. Surg. Oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol."},{"issue":"9","key":"4413_CR54","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1089\/thy.2013.0079","volume":"23","author":"H Mazeh","year":"2013","unstructured":"H. Mazeh, R.S. Sippel, Familial nonmedullary thyroid carcinoma. Thyroid: Official J. Am. Thyroid Association. 23(9), 1049\u20131056 (2013). https:\/\/doi.org\/10.1089\/thy.2013.0079","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"6","key":"4413_CR55","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1089\/thy.2019.0774","volume":"30","author":"Y Zhao","year":"2020","unstructured":"Y. Zhao, T. Yu, L. Chen, D. Xie, F. Wang, L. Fu, C. Cheng, Y. Li, X. Zhu, G. Miao, A germline CHEK2 mutation in a family with papillary thyroid cancer. Thyroid: Official J. Am. Thyroid Association. 30(6), 924\u2013930 (2020). https:\/\/doi.org\/10.1089\/thy.2019.0774","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"key":"4413_CR56","doi-asserted-by":"publisher","unstructured":"Landa, I., Ruiz-Llorente, S., Montero-Conde, C., Inglada-P\u00e9rez, L., Schiavi, F., Leskel\u00e4,S., Pita, G., Milne, R., Maravall, J., Ramos, I., And\u00eda, V., Rodr\u00edguez-Poyo, P., Jara-Albarr\u00e1n,A., Meoro, A., del Peso, C., Arribas, L., Iglesias, P., Caballero, J., Serrano, J.,Pic\u00f3, A., \u2026 Robledo, M. (2009). The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1\/USF2 transcription factors.PLoS genetics, 5(9), e1000637. https:\/\/doi.org\/10.1371\/journal.pgen.1000637","DOI":"10.1371\/journal.pgen.1000637"},{"issue":"5","key":"4413_CR57","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMoa1502449","volume":"373","author":"SK Gara","year":"2015","unstructured":"S.K. Gara, L. Jia, M.J. Merino, S.K. Agarwal, L. Zhang, M. Cam, D. Patel, E. Kebebew, Germline HABP2 mutation causing Familial nonmedullary thyroid cancer. N. Engl. J. Med. 373(5), 448\u2013455 (2015). https:\/\/doi.org\/10.1056\/NEJMoa1502449","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"4413_CR58","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/cancers12061441","volume":"12","author":"A Srivastava","year":"2020","unstructured":"A. Srivastava, B. Miao, D. Skopelitou, V. Kumar, A. Kumar, N. Paramasivam, E. Bonora, K. Hemminki, A. F\u00f6rsti, O.R. Bandapalli, A germline mutation in the POT1 gene is a candidate for Familial Non-Medullary thyroid cancer. Cancers. 12(6), 1441 (2020). https:\/\/doi.org\/10.3390\/cancers12061441","journal-title":"Cancers"},{"issue":"5","key":"4413_CR59","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/thy.2023.0564","volume":"34","author":"YJ Jiang","year":"2024","unstructured":"Y.J. Jiang, Y. Xia, Y.X. Hu, Z.J. Han, A.Y. Guo, T. Huang, Identification of P21 (CDKN1A) activated kinase 4 as a susceptibility gene for Familial Non-Medullary thyroid carcinoma. Thyroid: Official J. Am. Thyroid Association. 34(5), 583\u2013597 (2024). https:\/\/doi.org\/10.1089\/thy.2023.0564","journal-title":"Thyroid: Official J. Am. Thyroid Association"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04413-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:03:16Z","timestamp":1765908196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04413-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04413-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a systematic review and meta-analysis. No ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}